Novartis has exercised its call option to buy Nestle's remaining 52% stake in eyecare company Alcon for about $28 billion in cash.
Novartis to Pay $28B For Nestle Alcon StakeCourtesy Topix - Business News Mon, 01/04/2010 - 13:43
Novartis has exercised its call option to buy Nestle's remaining 52% stake in eyecare company Alcon for about $28 billion in cash. Tags:
Related itemsDisney to Take Controlling Stake in India's UTV
Samsung buys out Sony LCD venture
Yahoo up on Alibaba sale reports
Samsung SCX-4200 3-in-1 True Multifunction Printer
Sharp EL243SB Handheld Calculator with Hard Cover
|
Popular by tags WeekMonth |
Post new comment